CCMD
BMY icon

Cypress Capital Management (Delaware)’s Bristol-Myers Squibb BMY Stock Holding History

Cypress Capital Management (Delaware)’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,953
Closed -$281K – 23
2022
Q3 		$281K Hold
3,953
– – 0.05% 165
2022
Q2 		$304K Sell
3,953
-50
-1% -$3.81K 0.05% 165
2022
Q1 		$292K Sell
4,003
-800
-17% -$53.7K 0.04% 179
2021
Q4 		$299K Sell
4,803
-41
-0.8% -$2.4K 0.03% 183
2021
Q3 		$324K Hold
4,844
– – 0.04% 154
2021
Q2 		$324K Hold
4,844
– – 0.04% 154
2021
Q1 		$306K Sell
4,844
-851
-15% -$52.9K 0.04% 151
2020
Q4 		$353K Sell
5,695
-1,550
-21% -$95.3K 0.05% 144
2020
Q3 		$437K Hold
7,245
– – 0.07% 126
2020
Q2 		$426K Sell
7,245
-180
-2% -$10.8K 0.07% 126
2020
Q1 		$414K Hold
7,425
– – 0.08% 121
2019
Q4 		$477K Sell
7,425
-173,335
-96% -$9.93M 0.07% 125
2019
Q3 		$9.17M Buy
180,760
+26,425
+17% +$1.24M 1.5% 26
2019
Q2 		$7M Buy
154,335
+26,990
+21% +$1.26M 1.22% 34
2019
Q1 		$6.08M Buy
127,345
+12,475
+11% +$621K 1.12% 37
2018
Q4 		$5.97M Buy
114,870
+108,320
+1,654% +$5.82M 1.23% 33
2018
Q3 		$407K Buy
6,550
+100
+2% +$5.93K 0.07% 115
2018
Q2 		$357K Hold
6,450
– – 0.07% 118
2018
Q1 		$408K Hold
6,450
– – 0.08% 103
2017
Q4 		$395K Sell
6,450
-200
-3% -$12.5K 0.08% 107
2017
Q3 		$424K Hold
6,650
– – 0.09% 98
2017
Q2 		$371K Buy
+6,650
New +$362K 0.09% 89

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Cypress Capital Management (Delaware)'s BMY Position: Q4 2022 in Review

Cypress Capital Management (Delaware) sold out of Bristol-Myers Squibb (BMY) in Q4 2022, closing a stake of 3,953 shares — an estimated $281K sold.

Cypress Capital Management (Delaware) first reported a position in BMY in Q2 2017 and held it in 22 quarters. The position peaked at $9.17M in Q3 2019. 2,602 funds tracked by Wall St. Rank hold BMY as of Q4 2022.

  • Cypress Capital Management (Delaware) reported no remaining Bristol-Myers Squibb position as of Q4 2022 after selling out during the quarter.
  • Cypress Capital Management (Delaware) sold 3,953 Bristol-Myers Squibb shares in Q4 2022, an estimated $281K.
  • Cypress Capital Management (Delaware) first reported a position in Bristol-Myers Squibb in Q2 2017 and held it in 22 quarters.
  • Cypress Capital Management (Delaware)'s Bristol-Myers Squibb position peaked at $9.17M in Q3 2019.
  • 2,602 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2022.

Based on Cypress Capital Management (Delaware)'s 13F filing for Q4 2022.